Rose, You appear to be correct. I expected to see a short term drop followed by a steady rise. Maintaining weekly sales with half the expenses can't be a bad thing. I also agree with Raf. I think that the generic companies have reached max supply for now. If that Chinese article was accurate CCSB won't be able to provide additional API for at least a year. Sleven,